[{"NetIncomeLoss_3_Q3_USD":83393000.0,"Liabilities_0_Q3_USD":259012000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":19682000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":3170000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1601000.0,"InventoryGross_0_Q3_USD":27744000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"InterestIncomeOther_3_Q3_USD":16376000.0,"InterestIncomeOther_1_Q3_USD":3994000.0,"ContractWithCustomerAssetNetCurrent_0_Q3_USD":0.0,"InventoryFinishedGoods_0_Q3_USD":4535000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":6239000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-101706000.0,"PaymentsToAcquireInvestments_3_Q3_USD":866975000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1189888.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":26120000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":5179000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"ShareBasedCompensation_3_Q3_USD":85791000.0,"Assets_0_Q3_USD":2111043000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":1337405000.0,"CommonStockSharesIssued_0_Q3_shares":309402000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1872000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":19827000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":781324000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":8725000.0,"ContractWithCustomerLiability_0_Q3_USD":10600000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":88185000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":210916000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-1609000.0,"AssetsCurrent_0_Q3_USD":1407808000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":30000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":27235000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":47626000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":334046000.0,"OtherAssetsNoncurrent_0_Q3_USD":69409000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-5981000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":19317000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":565000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":571000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":309116000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":317495000.0,"CommonStockValue_0_Q3_USD":309000.0,"InventoryWriteDown_3_Q3_USD":2200000.0,"EarningsPerShareBasic_3_Q3_USD":0.27,"ValuationAllowancesAndReservesDeductions_3_Q3_USD":160177000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":30000.0,"InventoryRawMaterials_0_Q3_USD":5298000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":176762000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":393572000.0,"EarningsPerShareBasic_1_Q3_USD":-0.1,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"Revenues_1_Q3_USD":231092000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q3_investment":16.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":51151000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":40782000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-33641000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":86563000.0,"IncreaseDecreaseInInventories_3_Q3_USD":13466000.0,"RestrictedCashEquivalentsNoncurrent_0_Q3_USD":1636000.0,"Revenues_3_Q3_USD":717486000.0,"CostsAndExpenses_1_Q3_USD":273672000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-6438000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.157,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.188,"RevenueRemainingPerformanceObligation_0_Q3_USD":88900000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6731000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":344194000.0,"CostsAndExpenses_3_Q3_USD":631723000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":155678000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":9.61,"AccountsPayableCurrent_0_Q3_USD":47927000.0,"LiabilitiesCurrent_0_Q3_USD":201343000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":993211000.0,"InventoryWorkInProcess_0_Q3_USD":17911000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":309116000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":307437000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":335682000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":175689000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":55655000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":85791000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":26120000.0,"Goodwill_0_Q3_USD":63684000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":8210000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-1601000.0,"ValuationAllowancesAndReservesBalance_0_Q3_USD":27724000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":3170000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":34470000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":35329000.0,"NetIncomeLoss_1_Q3_USD":-32040000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":56385000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":0.0,"ReceivablesNetCurrent_0_Q3_USD":166138000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q3_USD":453000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3_Q3_USD":-893000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":15803000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":843000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":100092000.0,"InterestReceivable_0_Q3_USD":4500000.0,"AdditionalPaidInCapital_0_Q3_USD":2321441000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":10058000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"ShortTermInvestments_0_Q3_USD":853835000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":6800000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":115300000.0,"PreferredStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":21.84,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":1300000.0,"InventoryNet_0_Q3_USD":19319000.0,"CustomerRefundLiabilityCurrent_0_Q3_USD":19129000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-38021000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":2111043000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":102710000.0,"OperatingIncomeLoss_1_Q3_USD":-42580000.0,"OperatingIncomeLoss_3_Q3_USD":85763000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":231092000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":717486000.0,"CommonStockSharesAuthorized_0_Q3_shares":400000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":15868000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":16900406.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q3_USD":33100000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":55655000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.1,"EarningsPerShareDiluted_3_Q3_USD":0.26,"CommonStockSharesOutstanding_0_Q3_shares":309402000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":47074000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":67545000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-475958000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":85791000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":16219326.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":1329225000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":16055000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":9322000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":1852031000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":721000.0,"LongTermInvestments_0_Q3_USD":358079000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":4012000.0,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]